Owner TAKEDA CHEMICAL INDUSTRIES, LTD.

Inventors MORI, Masaaki; CHIKATSU, Tomoko; SATO, Shuji; NAGI, Toshimi; SUGO, Tsukasa

Pub. Number AU-A-2002354247

PCT Number PCT/JP02/13096

PCT Pub. Number WO2003/052414

Priority 2002-200556 09.07.02 JP; 2001-382174 14.12.01 JP

Filing date 13 December 2002

Wipo publication date 30 June 2003

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 025/00 Drugs for disorders of the nervous system

A61P 029/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 037/00 Drugs for immunological or allergic disorders

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 031/7088 - Compounds having three or more nucleosides or nucleotides

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12Q 001/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12P 021/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C07K 014/705 Peptides having more than 20 amino acids

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 001/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 015/85 Mutation or genetic engineering - for animal cells

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

G01N 033/15 Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

A61K 045/00 Medicinal preparations containing active ingredients not provided for in groups